PHARMA
Oxford BioDynamics To Conduct ALS Biomarker Program In Malaysia
The Penang subsidiary of Oxford BioDynamics will work towards developing diagnostic tests for amyotrophic lateral sclerosis.
Takeda, TiGenix Announce Phase III Trial Results For Crohn’s Disease Drug
A significantly greater proportion of patients in the treatment group versus the placebo group achieved combined remission at week 24.
Sorrento, CHA Biotech To Develop Natural Killer Cell Therapies
The venture will develop and commercialize modified cellular therapies based on activated killer cell technology.
Which Meds Are Best For You? Check systemsDock
Scientists have created a free online resource that makes screening for the right drug faster and more accurate.
China Resources Group To Acquire Majority Stake In GenesisCare
An investment consortium comprising China Resources Group and Macquarie Capital will acquire up to 74 percent of Australia-based GenesisCare.
China’s First HPV Vaccine Approved
GSK's Cervarix™ HPV vaccine could help to protect the health of millions of women in China at risk of cervical cancer.
A Step Closer To The World’s First Alzheimer’s Vaccine
Researchers in the US and Australia have developed a vaccine formulation that targets the two hallmark proteins of Alzheimer's disease.
A*STAR, MSD To Team Up On Macrocyclic Peptide Therapeutics
The two-year collaboration will focus on improving the delivery of macrocyclic peptides into cells.
China’s CStone Pharma Receives US$150 Million In Series A Financing
CStone Pharmaceuticals has closed a Series A round of financing with investments from Oriza Seed Venture Capital, Boyu Capital and WuXi Healthcare Ventures.
